Episurf Medical AB (publ) acquires financing of SEK 7 million by issuing convertible notes and warrants
Episurf Medical AB (publ) ("Episurf") acquires financing of 7 MSEK within the agreement signed with European Select Growth Opportunities Fund ("ESGO"). The capital injection shall be used for financing of the company's ongoing projects. Free warrants are allocated to existing shareholders to counteract dilution.On the evening of 2ndMay 2018, Episurf's board of directors approved the first transaction with ESGO and granted the issue of a first tranche of convertible notes and warrants not applying the shareholders' pre-emption following the general shareholders' meeting 9 April 2018 where a